The Dunamis Suture Anchor suture anchors are intended for use for the reattachment of soft tissue to bone for the following indications: Shoulder (Capsular Stabilization - Bankart Repair, - Anterior Shoulder Instability, - SLAP lesion repairs, - Capsular Shift or capsulolabral reconstructions, Acromioclavicular separation repairs, Deltoid Repairs, Rotator Cuff tear repairs, Biceps tenodesis), Elbow, Wrist, and Hand (Ulnar or radial collateral ligament reconstructions, Lateral epicondylitis repair, Biceps tendon reattachment), Knee (Extra-capsular repairs: - medial collateral ligament, - lateral collateral ligament, - posterior oblique ligament, Patellar realignment and tendon repairs: - vastus medialis obliquous advancement, Iliotibial band tenodesis), Foot and Ankle (Hallux valgus repairs, Medial or lateral instablility repairs/reconstructions, Achilles tendon repairs/reconstructions, Midfoot reconstructions, Metatarsal ligament/tendon repairs/reconstructions, Bunionectomy).

Device Description

The Dunamis Suture Anchor is a sterile single use implantable suture anchor system designed to provide fixation and reattachment of soft tissue to bone. The system consists of the following components: Suture Anchor, Teleflex Force Fiber Suture(s), USP Size 2, White & Blue, CoBraid Ultra High Molecular Weight Polyethylene, Inserter tool. The Dunamis Suture Anchor is packaged ready to use condition and provides aseptic O.R delivery. The system is provided complete and is not intended to be used or integrated with other bone anchor fixation implantable devices.

AI/ML Overview

The provided text describes information about the Dunamis Suture Anchor PEEK device, but it does not contain information about the acceptance criteria and the study that proves the device meets the acceptance criteria in the context of an AI/ML device.

The document is a 510(k) premarket notification acceptance letter and summary for a physical medical device (suture anchor). The performance data mentioned (Axial Pull-Out Strength, Biocompatibility, Sterilization Validation, Ethylene Oxide Residuals, Sterile Barrier Packaging performance, Aging of Sterile Medical Device) are for mechanical and material properties of the suture anchor, not for a software algorithm's performance.

Therefore, I cannot provide the requested information for acceptance criteria and study details for an AI/ML device from the given text.

If you have a document about an AI/ML device, please provide that text, and I will do my best to extract the relevant information.

Summary

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features the department's name in a circular arrangement around a symbol. The symbol consists of three stylized human profiles facing to the right, stacked on top of each other, representing health and human services.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

July 6, 2016

Dunamis LLC % Mr. Robert Dean Senior Consultant LexaMed 705 Front Street Toledo, Ohio 43605

Re: K160996

Trade/Device Name: Dunamis Suture Anchor PEEK 3.0mm, 3.5mm, 4.5mm, 6.5mm Regulation Number: 21 CFR 888.3040 Regulation Name: Smooth or threaded metallic bone fixation fastener Regulatory Class: Class II Product Code: MBI Dated: March 31, 2016 Received: April 8, 2016

Dear Robert Dean:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing

{1}------------------------------------------------

(21 CFR Part 807); labeling (21 CFR Parts 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set

forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours.

VincentJ. Devlin -S

for

Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Indications for Use		Form Approved: OMB No. 0910-0120
		Expiration Date: January 31, 2017
		See PRA Statement below.
510(k) Number (if known)	K160996
Device Name
Dunamis Suture Anchor PEEK	3.0mm, 3.5mm, 4.5mm, 5.5mm, 6.5mm
Indications for Use (Describe)
The Dunamis Suture Anchor suture anchors are intended for use for the reattachment of soft tissue to bone for the following indications:
Shoulder	Elbow, Wrist, and Hand
Capsular Stabilization	Ulnar or radial collateral ligament reconstructions
- Bankart Repair	Lateral epicondylitis repair
- Anterior Shoulder Instability	Biceps tendon reattachment
- SLAP lesion repairs
- Capsular Shift or capsulolabral reconstructions
Acromioclavicular separation repairs
Deltoid Repairs
Rotator Cuff tear repairs
Biceps tenodesis
	Knee
	Extra-capsular repairs:
	- medial collateral ligament
	- lateral collateral ligament
	- posterior oblique ligament
	Patellar realignment and tendon repairs:
Foot and Ankle	- vastus medialis obliquous advancement
Hallux valgus repairs	Iliotibial band tenodesis
Medial or lateral instablility
repairs/reconstructions
Achilles tendon repairs/reconstructions
Midfoot reconstructions
Metatarsal ligament/tendon
repairs/reconstructions
Bunionectomy
Type of Use (Select one or both, as applicable)
[X] Prescription Use (Part 21 CFR 801 Subpart D)	__ Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the
time to review instructions, search existing data sources, gather and maintain the data needed and complete
and review the collection of information. Send comments regarding this burden estimate or any other aspect
of this information collection, including suggestions for reducing this burden, to:
	Department of Health and Human Services
	Food and Drug Administration
	Office of Chief Information Officer
	Paperwork Reduction Act (PRA) Staff
	PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of
	information unless it displays a currently valid OMB number."
FORM FDA 3881 (8/14)	Page 1 of 1	EFPSC Pablishing Seeveres (301) 443-6 ? 40

{3}------------------------------------------------

510(K) Summary

Dunamis Suture Anchor PEEK 3.0mm, 3.5mm, 4.5mm, 5.5mm, 6.5mm

Date Prepared: June 1, 2016

A. Submitters Name:
Dr. Prithvi Raj Chavan Dunamis, LLC. 693 Sherling Lake Rd., Apt 122 Greenville, AL. 36037 (p) 731-217-2533 Email: dr.raj76@gmail.com
B. Company Contact
Dr. Prithvi Raj Chavan Dunamis, LLC. 693 Sherling Lake Rd., Apt 122 Greenville, AL. 36037
C. Device Name
Trade Name: Dunamis Suture Anchor PEEK 3.0mm, 3.5mm, 4.5mm, 5.5mm, 6.5mm Common Name: Suture Anchor Classification Name: fastener, fixation, non-degradable, soft tissue Product Code: MBI Regulation Number: 21CFR888.3040
Predicate Devices: The Dunamis Suture Anchor is substantially equivalent in Intended use and performance to the D. following legally marketed devices in commercial distribution: Smith & Nephew Osteoraptor 2.3 Suture Anchor K082215, Smith & Nephew Twinfix PK FT Suture Anchor K072785 .
E. Description of Device

· Suture Anchor
· Teleflex Force Fiber Suture(s), USP Size 2, White & Blue, CoBraid Ultra High Molecular Weight Polyethylene
· Inserter tool

The Dunamis Suture Anchor is packaged ready to use condition and provides aseptic O.R delivery. The system is provided complete and is not intended to be used or integrated with other bone anchor fixation implantable devices.

F. Intended Use

Indications

The Dunamis Suture Anchors are intended to be used for reattachment of soft tissue to bone for the following indications.

Shoulder

Capsular Stabilization Bankart Repair

{4}------------------------------------------------

Anterior Shoulder Instability Repair SLAP lesion repairs Capsular Shift or capsulolabral reconstructions Acromioclavicular separation repairs Deltoid Repairs Rotator Cuff tear repairs Biceps tenodesis Elbow Ulnar or radial collateral ligament reconstructions Lateral epicondylitis repair Biceps tendon reattachment Foot and Ankle Hallux valgus repairs Medial or lateral instability repairs/reconstructions Achilles tendon repairs/reconstructions Midfoot reconstructions Metatarsal ligament/tendon repairs/reconstructions Bunionectomy Knee Extra-capsular repairs: medial collateral ligament lateral collateral ligament posterior oblique ligament Patellar realignment and tendon repairs: vastus medialis obliquous advancement Iliotibial band tenodesis
G. Comparison of Technological Characteristics

The Dunamis Suture Anchor is substantially equivalent to the predicate device. The proposed and predicate devices are similar in design, operate on the same principles, have the same indications and intended use and exhibit similar fixation properties.

H. Summary Performance Data

The non-clinical performance testing conducted demonstrates that the insertion and fixation properties of the Dunamis Suture Anchor are substantially equivalent to the predicate devices. Overall Performance Testing includes:

Axial Pull-Out Strength
Biocompatibility ●
Sterilization Validation
Ethylene Oxide Residuals ●
. Sterile Barrier Packaging performance
. Aging of Sterile Medical Device

Regulation Number and Section

N/A